Financial Shenanigans

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

The Forensic Verdict

Topicus is a Constellation-owned vertical-software roll-up whose accounting profile is largely clean but contains four genuine judgment areas that institutional money should not gloss over: (1) the Asseco equity stake produced an FY2025 swing of more than $414M of non-operating income items, including a $260.5M revaluation loss and a Q1 2025 in-period adjustment that increased originally reported net income by $36.9M — a soft restatement, not a formal one; (2) the headline CFO/Net Income ratio of 5.9x in FY2025 collapses to roughly 2.0x once Asseco non-cash items are normalized, and free cash flow after acquisitions is only $140M, not the $472M FCF headline; (3) the controlling-shareholder governance is unusual — Constellation Software holds a super-voting share, the CFO Jamal Baksh is the CFO of CSI and is paid entirely by CSI, and the bonus plan is built on a non-IFRS "Net income for bonus purposes" that adds back impairments and intangible amortization; (4) related-party flows with CSI/Vela/CEO-affiliated entities are properly disclosed but represent a recurring 0.7%-of-revenue annuity that requires monitoring. The dominant offsetting evidence is clean: no regulatory action, no auditor change (KPMG continuing), no short-seller report, DSO stable at 49-52 days, capex policy conservative, and acquisitions correctly classified in investing activities. Risk grade: Watch. The single data point that would most change the grade is any audit-committee disclosure of contingent-consideration earn-out re-measurement that materially affects operating income in a future period.

Shenanigans Scorecard — All 13 Categories

Breeding Ground

The governance setup is structurally permissive — a controlling shareholder with super-voting rights, a shared CFO, board members drawn from CSI's orbit, and a bonus plan that explicitly adds back intangible amortization. None of this is hidden, all of it is disclosed in the management information circular, and Constellation's parent track record is among the cleanest in the TSX universe. But "the breeding ground is OK because the parent is honest" is not a forensic defense — it is a bet on culture.

The bonus design merits a closer read. ROIC (net income for bonus purposes ÷ average invested equity capital) adds back intangible amortization and impairments. In a serial-acquirer, this means a manager is judged on the cash earnings of an acquired book before recognizing the cost of the asset that produced those cash earnings. That is the same construct CSI uses, and it has not produced visible misbehavior in 25 years at the parent — but it is structurally pro-M&A and therefore pro-acquisition-write-up. The 75% lock-up of after-tax bonus into Subordinate Voting Shares held for four years is the offsetting protective design.

Earnings Quality

Reported operating income is clean and recurring. The risk lives below the operating line, where FY2025 net income was distorted by roughly $414M of Asseco-related items — a $260.5M revaluation loss, a $119.5M derivative gain, a $35.4M dilution gain, a $38.5M fair-value gain on equity securities, and the rest from finance costs and dilution. The MD&A discloses each piece, but a reader who only looks at headline EPS will mis-read the year.

Revenue versus receivables — clean

Receivables-as-a-percent-of-revenue rose from 9.5% (FY2018, pre-IPO) to 15.9% (FY2023) and has stabilized at 14.5-14.9% since. DSO ran 17 days FY18, 38 days FY19, 50-52 days FY23-25 — the step-change happened when the business shifted toward Europe-heavy SaaS/maintenance billing, not a recent acceleration. FY2025 AR grew 22.0% against revenue growth of 19.9% — a 2.1pp gap, well within sector noise. No flag.

Operating income is clean; net income is not

The FY2021 $-2,134M net income was the IPO-related redeemable preferred securities revaluation, a well-disclosed accounting artifact of the February 2021 spin-off from Constellation — not an operating event. The FY2025 dip to $49.1M was the Asseco revaluation. Operating income, by contrast, has compounded smoothly: 61→71→112→129→121→183→214→275. This pattern — clean operating income with noisy "other" income — is the right place for the noise to live, but it makes consensus EPS a misleading anchor and forces a reader to model on EBITA or operating income.

The Asseco episode — disclosed, but a soft restatement

Net of all six items, Asseco was a ~$102M expense on FY2025 net income before tax. The economic reality — Topicus bought 24.84% of Asseco for $683M ($197M Q1 plus $485M Q4) — is a normal strategic investment. The accounting created a swing because the company changed measurement method (FVOCI → fair value through P&L on the derivative → equity method at cost) during the same fiscal year. Watch for further re-measurement if Topicus exercises additional Asseco options.

Capitalized costs and reserves

Capex/Depreciation has run at roughly 5% for eight straight years. That is not an "aggressive capitalization" pattern — it is the opposite. The depreciation/amortization line is overwhelmingly intangible amortization on acquired customer relationships and software. The risk in this picture is not capitalized R&D (there is essentially none); the risk is that bonus comp adds back the amortization, which structurally rewards the acquisition that generated the intangible.

Cash Flow Quality

Reported CFO of $484.9M FY2025 against $82.4M consolidated net income is a 5.9x ratio that screams. Normalized for the non-cash Asseco revaluation, the ratio drops to roughly 2.0x, in line with FY2022-FY2024. The real cash-quality issue is not the CFO/NI ratio — it is that CFO for a roll-up overstates the run-rate cash conversion of the business, because acquisitions bring acquired CFO that is paid for in investing.

CFO/NI normalized — flag is the headline number, not the underlying business

The FY2021 and FY2025 anomalies are non-cash items (preferred securities revaluation and Asseco revaluation respectively) hitting net income without touching cash. The five clean years FY2018-FY2020 plus FY2022-FY2024 show a stable 2.0-2.6x CFO/NI ratio that exactly equals the operating income / net income ratio you would expect when a company has ~$200M of annual non-cash intangible amortization against ~$100-160M of net income.

The flag — FCF after acquisitions

Working-capital contribution to CFO

FY2021 is the preferred-securities reversal. FY2025 is dominated by the Asseco revaluation reversal ($260.5M non-cash expense reversed in CFO bridge), partly offset by payables expansion that the FY2025 MD&A quantifies at $33.4M of "non-cash operating working capital" plus payables growth in accounts payable & accrued liabilities ($135M increase on the balance sheet, partially acquisition-related). DPO moved from 102 days FY24 to 113 days FY25 — a 10-day extension is a measurable working-capital lifeline. Importantly, the Summit Stocks substack post on the Q1 2026 results explicitly notes "in Q1 2025, Topicus delayed payments to its suppliers, increasing the accounts payable balance by $37.4 million. This reversed in the latest quarter, with a decrease of $4.7 million" — supplier-payment timing is being used by external readers as a CFO-quality signal.

Metric Hygiene

Management's preferred operating metric is FCFA2S — "Free Cash Flow Available to Shareholders" — defined as CFO less interest paid (on debt and leases), credit-facility transaction costs, lease principal payments, capex, plus interest and dividends received, less the portion attributable to non-controlling interests. It is not standard FCF.

FCFA2S reconciliation — what management subtracts

Two observations. First, including interest paid (on both debt and leases) in the deduction is more conservative than the standard CFF-FCF gap — most companies leave interest paid in CFO untouched. Second, lease principal payments are not a financing item under IFRS but management treats them as recurring cash drains for shareholders — also conservative. Third, the NCI haircut of $154.4M assumes 32% of the business does not belong to Topicus shareholders. The result is a metric that reads as $257.0M but corresponds to economic FCF before reinvestment of around $411M, with neither number useful for assessing capital deployment because the business spends $332M of FCF on acquisitions in the same year.

Heatmap — risk by category over time

What to Underwrite Next

The forensic work above does not change the thesis on Topicus — it changes the inputs. Specifically, three concrete diligence items.

1. The FY2026 Q1 and Q2 Asseco accounting. The $260.5M Q4 2025 revaluation loss reduced the carrying value of Asseco to $199.3M cost basis. If management changes method again (e.g., re-elects fair value through OCI after additional purchases) or marks the investment to a different basis on consolidation of additional tranches, a similar swing in finance and other income is possible. The signal that would downgrade: a third measurement change in twelve months on the same investment, or a non-cash impairment of the Asseco carrying value. The signal that would upgrade: a clean equity-method accounting through 2026 with disclosure of Asseco's contribution to Topicus's share of net income.

2. Contingent-consideration earn-outs. The FY2025 balance is $45.4M; the FY2025 income statement absorbed $2.7M of upward revision (expense) compared to a $1.4M release in FY2024. Earn-outs are a recurring lever that flows through "Other, net" inside operating expenses and is not classified as one-time. Monitor the next two quarterly reports for the cumulative expense, and flag if more than $6M of upward revisions hit a single quarter — that would indicate either over-aggressive original purchase price allocations or genuinely better acquired-business performance.

3. Receivables-from-related-parties and the Dutch tax dispute. The $1.6M FY2025 receivable from CSI-controlled entities is small; the $0.9M payable to CSI is small. The structural question is whether the $17.6M annual gross flow between Topicus, CSI, and Vela compounds as Topicus grows. Separately, the Dutch Tax Authority is challenging the deductibility of the employee bonus program for 2016-2018; up to $9.4M unreserved exposure is disclosed. The signal that would downgrade: an adverse ruling or a recognized provision. The signal that would upgrade: settlement or a positive court ruling.

Position-sizing implication. The forensic profile justifies a modest valuation haircut compared with Constellation parent — perhaps 5-10% lower EV/CFO multiple — to compensate for the bonus-comp structure's pro-M&A bias, the FCFA2S definitional looseness, and the Asseco-related noise. It does not justify a thesis change, a sizing cap, or a covenant concern. Risk grade: Watch. This accounting deserves to be monitored, not feared. The right reaction is to model Topicus on operating income and FCF-after-acquisitions, not headline EPS or FCFA2S, and to keep the Asseco line item in a dedicated tracking column for at least four more quarters.